(19)
(11) EP 4 340 943 A1

(12)

(43) Date of publication:
27.03.2024 Bulletin 2024/13

(21) Application number: 22731078.6

(22) Date of filing: 18.05.2022
(51) International Patent Classification (IPC): 
A61P 35/00(2006.01)
A61K 39/00(2006.01)
C07K 16/28(2006.01)
(52) Cooperative Patent Classification (CPC):
C07K 16/2818; C07K 16/2827; A61P 35/00; A61K 2039/545; A61K 2039/507; A61K 2039/505; C07K 2317/75; C07K 2317/76; C07K 2317/74; A61K 2039/57
(86) International application number:
PCT/EP2022/063450
(87) International publication number:
WO 2022/243378 (24.11.2022 Gazette 2022/47)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 18.05.2021 US 202163190016 P

(71) Applicant: Kymab Limited
Cambridge CB22 3AT (GB)

(72) Inventors:
  • SAINSON, Richard Charles Alfred
    Cambridge CB22 3AT (GB)
  • HOLMES, Rosalind
    65926 Frankfurt am Main (DE)

(74) Representative: Heath, Abigail et al
Kilburn & Strode LLP Lacon London 84 Theobalds Road
London WC1X 8NL
London WC1X 8NL (GB)

   


(54) USES OF ANTI-ICOS ANTIBODIES